Skip to main content
SpringerLink
Log in

FDG PET in solitary metastastic/secondary tumor of the kidney: A report of three cases and a review of the relevant literature

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Metastatic tumors or secondary lymphoma of the kidney are rare and can often be missed on conventional computed tomography (CT) imaging. On the other hand, many types of metastatic tumor or lymphoma can be detected clearly as hotspots of elevated uptake on FDG PET. However, excreted FDG present in the urinary tract mimics these findings and interferes with image reading. Careful investigation of the renal cortex by FDG PET and review of anatomical images, such as the findings of CT and MRI, have important roles in the detection of renal tumor. Here, we present three cases of solitary metastatic/secondary tumor of the kidney, and discuss the features of the lesions on FDG PET in comparison with their appearance on CT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hofer C, Kubler H, Hartung R, Breul J, Avril N. Diagnosis and monitoring of urological tumors using positron emission tomography.Eur Urol 2001; 40: 481–487.

    Article  PubMed  CAS  Google Scholar 

  2. Bracken RB, Chica G, Johnson DE, Luna M. Secondary renal neoplasms: an autopsy study.South Med J 1979; 72: 806–807.

    PubMed  CAS  Google Scholar 

  3. Pollack HM, Banner MP, Amendola MA. Other malignant neoplasms of the renal parenchyma.Semin Roentgenol 1987; 22: 260–274.

    Article  PubMed  CAS  Google Scholar 

  4. Klinger M. Secondary tumors of the genitourinary tract.J Urol 1951; 65: 144–153.

    PubMed  CAS  Google Scholar 

  5. Abrams H, Spira R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases.Cancer 1950; 3: 74–85.

    Article  PubMed  CAS  Google Scholar 

  6. Wagle DG, Moore RH, Murphy GP. Secondary carcinomas of the kidney.J Urol 1975; 114: 30–32.

    PubMed  CAS  Google Scholar 

  7. Newsam JE, Tulloch WS. Metastatic tumours in the kidney.Br J Urol 1966; 38: 1–6.

    Article  PubMed  CAS  Google Scholar 

  8. Choyke PL, White EM, Zeman RK, Jaffe MH, Clark LR. Renal metastases: clinicopathologic and radiologic correlation.Radiology 1987; 162: 359–363.

    PubMed  CAS  Google Scholar 

  9. Peterson RO.Urologic Pathology. Philadelphia; Lippincott, 1992: 127.

    Google Scholar 

  10. Sanchez-Ortiz RF, Madsen LT, Bermejo CE, Wen S, Shen Y, Swanson DA, et al. A renal mass in the setting of a nonrenal malignancy: When is a renal tumor biopsy appropriate?Cancer 2004; 15;101: 2195–2201.

    Article  Google Scholar 

  11. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer.Oncologist 2004; 9: 633–643.

    Article  PubMed  Google Scholar 

  12. Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, et al. FDG-PET in staging lung cancer: how does it change the algorithm?Lung Cancer 2004; 44: 175–181.

    Article  PubMed  CAS  Google Scholar 

  13. Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging.Ann Thorac Surg 1995; 60: 1573–1582.

    Article  PubMed  CAS  Google Scholar 

  14. Weder W, Schmid RA, Bruchhaus H, Hillinger S, von Schulthess GK, Steinert HC. Detection of extrathoracic metastases by positron emission tomography in lung cancer.Ann Thorac Surg 1998; 66: 886–893.

    Article  PubMed  CAS  Google Scholar 

  15. Leisure GP, Vesselle HJ, Faulhaber PF, O’Donnell JK, Adler LP, Miraldi F. Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis.J Nucl Med Technol 1997; 25: 115–119.

    PubMed  CAS  Google Scholar 

  16. Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.J Urol 2004; 171: 1806–1809.

    Article  PubMed  Google Scholar 

  17. Lechevallier E, Andre M, Barriol D, Daniel L, Eghazarian C, De Fromont M, et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance.Radiology 2000; 216: 506–510.

    PubMed  CAS  Google Scholar 

  18. Wood BJ, Khan MA, McGovern F, Harisinghani M, Hahn PF, Mueller PR. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management.J Urol 1999; 161: 1470–1474.

    Article  PubMed  CAS  Google Scholar 

  19. Gibbons RP, Bush WH Jr, Burnett LL. Needle tract seeding following aspiration of renal cell carcinoma.J Urol 1977; 118:865–867.

    PubMed  CAS  Google Scholar 

  20. Kiser GC, Totonchy M, Barry JM. Needle tract seeding after percutaneous renal adenocarcinoma aspiration.J Urol 1986; 136: 1292–1293.

    PubMed  CAS  Google Scholar 

  21. Slywotzky C, Maya M. Needle tract seeding of transitional cell carcinoma following fine-needle aspiration of a renal mass.Abdom Imaging 1994; 19: 174–176.

    Article  PubMed  CAS  Google Scholar 

  22. Campbell SC, Novick AC, Herts B, Fischler DF, Meyer J, Levin HS, et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity.Urology 1997; 50: 25–29.

    Article  PubMed  CAS  Google Scholar 

  23. Herts BR, Baker ME. The current role of percutaneous biopsy in the evaluation of renal masses.Semin Urol Oncol 1995; 13:254–261.

    PubMed  CAS  Google Scholar 

  24. Goethuys H, Van Poppel H, Oyen R, Baert L. The case against fine-needle aspiration cytology for small solid kidney tumors.Eur Urol 1996; 29: 284–287.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, 980-8574, Sendai, Japan

    Tomohiro Kaneta, Takashi Hakamatsuka, Takayuki Yamada, Kei Takase, Akihiro Sato, Shuichi Higano, Shoki Takahashi & Shogo Yamada

  2. Department of Nuclear Medicine and Radiology, Institute of Development, Aging and Cancer, Tohoku University, Japan

    Shigeo Kinomura & Hiroshi Fukuda

Authors
  1. Tomohiro Kaneta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Hakamatsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takayuki Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kei Takase
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akihiro Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shuichi Higano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shigeo Kinomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroshi Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shoki Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shogo Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomohiro Kaneta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaneta, T., Hakamatsuka, T., Yamada, T. et al. FDG PET in solitary metastastic/secondary tumor of the kidney: A report of three cases and a review of the relevant literature. Ann Nucl Med 20, 79–82 (2006). https://doi.org/10.1007/BF02985596

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02985596

Key words

Search

Navigation